New drug combo tested for Tough-to-Treat blood cancer
Disease control
Not yet recruiting
This early-stage study is testing a new two-drug combination (lonitoclax and azacitidine) for adults whose acute myeloid leukemia has returned or hasn't responded to prior treatments. The main goals are to find a safe and effective dose and to see how well the body handles the dr…
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC